Clinical Trial Update: Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating rheumatologic effects of anastrozole and letrozole as adjuvant therapy in post-menopausal women with breast cancer; results posted afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anastrozole (Anastrozole)
• Letrozole (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2021-05-24